Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07224906 · ClinicalTrials.gov registry record
Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization
A clinical trial of Pulmonary Hypertension and Valve Disease, Heart, sponsored by HemoCept.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT07224906: Recruiting study of Pulmonary Hypertension and Valve Disease, Heart, sponsored by HemoCept.
NCT07224906 is a study of Pulmonary Hypertension and Valve Disease, Heart that is actively recruiting participants, run by HemoCept. The registered enrollment target is 50 participants, below the 613-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07224906, a study of Pulmonary Hypertension and Valve Disease, Heart, is actively recruiting participants, sponsored by HemoCept.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.
Primary Outcome
The correlation of HemoCept device measurements to Pulmonary Capillary Wedge Pressure (PCWP) measured during right heart catheterization.
Conditions Studied
Study Locations (1)
Colorado
- Boulder Heart - Boulder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-12-01 |
| Est. Completion | 2026-03-30 |
What NCT07224906 shows while recruiting
NCT07224906 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 613-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (92% lower).
The record links to 3 conditions, with Pulmonary Hypertension appearing as the primary indexed condition, and to 0 interventions.
NCT07224906 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT07224906 about?
NCT07224906 is a clinical study titled "Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization". The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.
What is the current status of trial NCT07224906?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2025-12-01. Estimated completion is 2026-03-30.
What conditions does trial NCT07224906 study?
This clinical trial studies the following conditions: Pulmonary Hypertension, Valve Disease, Heart, Congestive Heart Failure(CHF).
Who is sponsoring clinical trial NCT07224906?
This trial is sponsored by HemoCept, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07224906 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07224906's enrollment target sits among peer trials
50 40th of 72 higher than 32 of 72 other Pulmonary Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pulmonary Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
RECRUITING
-
Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
RECRUITING
-
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
RECRUITING · NA
-
Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
RECRUITING
-
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
RECRUITING · Phase 3
-
Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI